MX2020008988A - Sistemas y metodos para la identificacion de contaminantes virales. - Google Patents
Sistemas y metodos para la identificacion de contaminantes virales.Info
- Publication number
- MX2020008988A MX2020008988A MX2020008988A MX2020008988A MX2020008988A MX 2020008988 A MX2020008988 A MX 2020008988A MX 2020008988 A MX2020008988 A MX 2020008988A MX 2020008988 A MX2020008988 A MX 2020008988A MX 2020008988 A MX2020008988 A MX 2020008988A
- Authority
- MX
- Mexico
- Prior art keywords
- systems
- methods
- viral contaminants
- sample acquisition
- rna viral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente divulgación se refiere a un proceso de preparación de muestra simplificado, VERA (enriquecimiento viral mediante artefactos de reducción), para inclinar el material genómico total en favor de genomas virales de ADN/ARN. Esta reducción de artefactos genómicos hospedadores se puede completar en <8 horas a partir de la adquisición de muestras. Usando un protocolo de preparación de genotecas rápido (~15 minutos) y secuenciación de nanoporos en tiempo real, se puede identificar la posible contaminación viral, por ejemplo, contaminación viral de ARN, en menos de un día de trabajo a partir de la adquisición de la muestra.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862636546P | 2018-02-28 | 2018-02-28 | |
US201862725543P | 2018-08-31 | 2018-08-31 | |
PCT/US2019/019355 WO2019168774A1 (en) | 2018-02-28 | 2019-02-25 | Systems and methods for identifying viral contaminants |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020008988A true MX2020008988A (es) | 2020-09-28 |
Family
ID=65724549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020008988A MX2020008988A (es) | 2018-02-28 | 2019-02-25 | Sistemas y metodos para la identificacion de contaminantes virales. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20190264293A1 (es) |
EP (1) | EP3759242A1 (es) |
JP (2) | JP2021514609A (es) |
KR (1) | KR20200127979A (es) |
CN (1) | CN111771000A (es) |
AU (1) | AU2019227531A1 (es) |
BR (1) | BR112020013426A2 (es) |
CA (1) | CA3088906A1 (es) |
IL (1) | IL276699A (es) |
MX (1) | MX2020008988A (es) |
SG (1) | SG11202006310PA (es) |
TW (1) | TW202000922A (es) |
WO (1) | WO2019168774A1 (es) |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5173418A (en) | 1985-05-10 | 1992-12-22 | Benzon Pharma, A/S | Production in Escherichia coli of extracellular Serratia spp. hydrolases |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0974660A1 (en) * | 1998-06-19 | 2000-01-26 | Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) | Newcastle disease virus infectious clones, vaccines and diagnostic assays |
US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
US20030044771A1 (en) * | 2001-08-30 | 2003-03-06 | Anderson Norman G. | Method for discovering new infectious particles |
KR100562195B1 (ko) | 2002-03-08 | 2006-03-20 | 에이에스엠엘 네델란즈 비.브이. | 리소그래피용 마스크, 마스크 제조방법, 리소그래피장치및 디바이스제조방법 |
US7582298B2 (en) | 2006-06-02 | 2009-09-01 | Regeneron Pharmaceuticals, Inc. | High affinity antibodies to human IL-6 receptor |
US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
PL2178916T3 (pl) | 2007-07-31 | 2015-08-31 | Regeneron Pharma | Ludzkie przeciwciała przeciwko ludzkiemu CD20 i sposób ich zastosowania |
US8309088B2 (en) | 2007-08-10 | 2012-11-13 | Regeneron Pharmaceuticals, Inc. | Method of treating osteoarthritis with an antibody to NGF |
JO3672B1 (ar) | 2008-12-15 | 2020-08-27 | Regeneron Pharma | أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9). |
RU2522002C2 (ru) | 2009-06-26 | 2014-07-10 | Ридженерон Фармасьютикалз, Инк. | Легковыделяемые биспецифические антитела с природным иммуноглобулиновым форматом |
JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
JO3340B1 (ar) | 2010-05-26 | 2019-03-13 | Regeneron Pharma | مضادات حيوية لـعامل تمايز النمو 8 البشري |
JOP20190250A1 (ar) | 2010-07-14 | 2017-06-16 | Regeneron Pharma | صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب |
AR083044A1 (es) | 2010-09-27 | 2013-01-30 | Regeneron Pharma | Anticuerpos anti-cd48 y usos de los mismos |
US8945559B2 (en) | 2010-10-06 | 2015-02-03 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies |
JO3756B1 (ar) | 2010-11-23 | 2021-01-31 | Regeneron Pharma | اجسام مضادة بشرية لمستقبلات الجلوكاجون |
AR087329A1 (es) | 2011-06-17 | 2014-03-19 | Regeneron Pharma | Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana |
PL2780368T3 (pl) | 2011-11-14 | 2018-06-29 | Regeneron Pharmaceuticals, Inc. | Kompozycje i sposoby do zwiększania masy mięśni i siły mięśni poprzez swoiste antaganizowanie GDF8 i/lub aktywiny A |
CN104169299B (zh) | 2012-01-23 | 2018-06-05 | 瑞泽恩制药公司 | 含抗Ang-2 抗体的稳定化制剂 |
JO3820B1 (ar) | 2012-05-03 | 2021-01-31 | Regeneron Pharma | أجسام مضادة بشرية لـ fel d1وطرق لاستخدامها |
TW201843172A (zh) | 2012-06-25 | 2018-12-16 | 美商再生元醫藥公司 | 抗-egfr抗體及其用途 |
CA2881679C (en) | 2012-08-13 | 2021-01-26 | Regeneron Pharmaceuticals, Inc. | Anti-pcsk9 antibodies with ph-dependent binding characteristics |
JOP20200236A1 (ar) | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
JO3405B1 (ar) | 2013-01-09 | 2019-10-20 | Regeneron Pharma | الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها |
JO3532B1 (ar) | 2013-03-13 | 2020-07-05 | Regeneron Pharma | الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها |
TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法 |
JP6404314B2 (ja) | 2013-03-15 | 2018-10-10 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | Il−33拮抗薬とその使用法 |
TWI641620B (zh) | 2013-08-21 | 2018-11-21 | 再生元醫藥公司 | 抗-prlr抗體及其用途 |
TWI681969B (zh) | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對pd-1的人類抗體 |
TWI680138B (zh) | 2014-01-23 | 2019-12-21 | 美商再生元醫藥公司 | 抗pd-l1之人類抗體 |
CA2940685C (en) | 2014-03-11 | 2023-10-24 | Regeneron Pharmaceuticals, Inc. | Anti-egfrviii antibodies and uses thereof |
TWI754319B (zh) | 2014-03-19 | 2022-02-01 | 美商再生元醫藥公司 | 用於腫瘤治療之方法及抗體組成物 |
WO2015171523A1 (en) | 2014-05-05 | 2015-11-12 | Regeneron Pharmaceuticals, Inc. | Humanized c5 and c3 animals |
JO3701B1 (ar) | 2014-05-23 | 2021-01-31 | Regeneron Pharma | مضادات حيوية بشرية لمتلازمة الشرق الأوسط التنفسية - بروتين كورونا فيروس الشوكي |
SG11201701711VA (en) | 2014-09-16 | 2017-04-27 | Regeneron Pharma | Anti-glucagon antibodies and uses thereof |
TWI710573B (zh) | 2015-01-26 | 2020-11-21 | 美商再生元醫藥公司 | 抗伊波拉病毒醣蛋白之人類抗體 |
US10626443B2 (en) * | 2016-08-10 | 2020-04-21 | Grail, Inc. | Methods of analyzing nucleic acid fragments |
-
2019
- 2019-02-25 MX MX2020008988A patent/MX2020008988A/es unknown
- 2019-02-25 US US16/284,133 patent/US20190264293A1/en active Pending
- 2019-02-25 CA CA3088906A patent/CA3088906A1/en active Pending
- 2019-02-25 BR BR112020013426-0A patent/BR112020013426A2/pt unknown
- 2019-02-25 AU AU2019227531A patent/AU2019227531A1/en active Pending
- 2019-02-25 WO PCT/US2019/019355 patent/WO2019168774A1/en unknown
- 2019-02-25 EP EP19710230.4A patent/EP3759242A1/en active Pending
- 2019-02-25 KR KR1020207021199A patent/KR20200127979A/ko not_active Application Discontinuation
- 2019-02-25 CN CN201980015306.5A patent/CN111771000A/zh active Pending
- 2019-02-25 JP JP2020538674A patent/JP2021514609A/ja active Pending
- 2019-02-25 SG SG11202006310PA patent/SG11202006310PA/en unknown
- 2019-02-26 TW TW108106430A patent/TW202000922A/zh unknown
-
2020
- 2020-08-13 IL IL276699A patent/IL276699A/en unknown
-
2024
- 2024-01-19 JP JP2024006450A patent/JP2024041979A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN111771000A (zh) | 2020-10-13 |
JP2024041979A (ja) | 2024-03-27 |
AU2019227531A1 (en) | 2020-10-15 |
SG11202006310PA (en) | 2020-07-29 |
IL276699A (en) | 2020-09-30 |
TW202000922A (zh) | 2020-01-01 |
CA3088906A1 (en) | 2019-09-06 |
US20190264293A1 (en) | 2019-08-29 |
WO2019168774A1 (en) | 2019-09-06 |
KR20200127979A (ko) | 2020-11-11 |
EP3759242A1 (en) | 2021-01-06 |
JP2021514609A (ja) | 2021-06-17 |
BR112020013426A2 (pt) | 2020-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107663521B (zh) | 血浆游离核酸提取试剂盒及其应用 | |
Moldován et al. | Multi-platform sequencing approach reveals a novel transcriptome profile in pseudorabies virus | |
Riemann et al. | Comparison of manual and automated nucleic acid extraction from whole‐blood samples | |
DE60316642T2 (de) | Verbessertes Verfahren zur Bisulfit-Behandlung | |
EP4293673A3 (en) | Detection instrument for digital pcr and quantitative detection method for digital pcr | |
CN109371010A (zh) | 一种磁珠法血浆游离dna提取试剂盒及提取方法 | |
Dukes et al. | bone DNA extraction and purification using silica‐coated paramagnetic beads | |
CN101851617A (zh) | 可用于高通量全自动化提取的磁珠法病毒核酸提取方法 | |
WO2018184495A1 (zh) | 一步法构建扩增子文库的方法 | |
DE102017204267A1 (de) | Verfahren zur anreicherung von zellen aus einer probe und der nachfolgenden nukleinsäureisolierung aus diesen zellen | |
Lothert et al. | A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications | |
CN103060429A (zh) | 一种天赋潜能评估的飞行质谱生物芯片及其检测方法 | |
CN110358816B (zh) | 一种用于鸡来源细胞pcr检测的引物组、试剂盒及应用 | |
Shuikan et al. | High-throughput sequencing and metagenomic data analysis | |
MX2020008988A (es) | Sistemas y metodos para la identificacion de contaminantes virales. | |
Agüero et al. | A fully automated procedure for the high-throughput detection of avian influenza virus by real-time reverse transcription–polymerase chain reaction | |
DE10153957A1 (de) | Verfahren zur Isolierung von Nukleinsäuren | |
CN107815450B (zh) | 用于核酸纯化的缓冲液、核酸纯化试剂盒及其应用 | |
CN105506084B (zh) | 快速高效检测基因组dna羟甲基化的方法及试剂盒 | |
CN103114139A (zh) | 一种基于连接酶反应的多特异位点dna甲基化电化学检测方法 | |
CN113736895B (zh) | 一种超声诱变的鼠伤寒沙门氏菌hisD基因InDel分子标记及应用 | |
EA202091601A1 (ru) | Системы и способы идентификации вирусных контаминантов | |
CN101024851A (zh) | 基于梯状回收的基因拷贝数鉴定和各拷贝序列获得的方法 | |
JP2010029104A (ja) | 菌数測定のための前処理方法及び菌数測定前処理装置 | |
CN116926065B (zh) | 一种适用于病原微生物和宿主残留检测的核酸提取试剂盒及其提取方法 |